Psyence Biomedical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Millions USD. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	7.44	6.14	0.73	1.33	1.75
Cash & Short-Term Investments	7.44	6.14	0.73	1.33	1.75
Cash Growth	21.35%	736.78%	-45.05%	-23.91%	-
Other Receivables	0.36	0.14	0.04	0.15	0.04
Total Trade Receivables	0.36	0.14	0.04	0.15	0.04
Other Current Assets	1.3	0.29	0.35	0.11	0.04
Total Current Assets	9.11	6.56	1.13	1.59	1.83
Net Property, Plant & Equipment	0.01	0.01	0.01	-	-
Long-Term Investments	8.06	0.75	-	-	-
Other Long-Term Assets	0.39	-	-	-	-
Total Assets	17.57	7.32	1.13	1.59	1.83
Accounts Payable	0.41	0.39	3.55	1.79	0.13
Short-Term Debt	-	-	7.66	-	-
Other Current Liabilities	0.22	0.2	0.9	-	-
Total Current Liabilities	0.62	0.59	12.1	1.79	0.13
Total Liabilities	0.62	0.59	12.1	1.79	0.13
Common Stock	78.75	61.75	46.13	5.93	4.54
Additional Paid-in Capital	1.58	1.42	0.36	0.17	0.26
Retained Earnings	-63.38	-56.45	-57.46	-6.3	-3.09
Shareholders' Equity	16.94	6.72	-10.97	-0.2	1.7
Total Liabilities & Equity	17.57	7.32	1.13	1.59	1.83
Total Debt	0	0	7.66	0	0
Net Cash (Debt)	7.44	6.14	-6.92	1.33	1.75
Net Cash Growth	21.35%	-	-	-23.91%	-
Net Cash Per Share	13.48	198.63	-3970.30	996.92	-
Book Value	16.94	6.72	-10.97	-0.2	1.7
Book Value Per Share	30.68	217.63	-6291.59	-149.76	-
Tangible Book Value	16.94	6.72	-10.97	-0.2	1.7
Tangible Book Value Per Share	30.68	217.63	-6291.59	-149.76	-

SEC Filings: 10-K · 10-Q